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Abstract
Laparoscopic sleeve gastrectomy (SG) is the most commonly done bariatric 
procedure worldwide due to its technical ease. However, the physiologic effects 
of this procedure have limitations on glucose homeostasis for patients with type 2 
Diabetes Mellitus (T2DM). This is due to the insufficient physiologic modulations 
from intestinal hormones. The Roux-en-Y gastric bypass (RYGB) has been proven to 
have better T2DM remission than SG due to more pronounced physiologic changes 
from foregut and hindgut hormone modulations. However, RYGB is technically 
challenging to perform and is accompanied by many potential postoperative com-
plications, especially in terms of nutrition. The addition of an intestinal bypass to 
SG also induces said intestinal hormone changes to enhance diabetes remission. This 
chapter discusses the intestinal bypass that may be added to SG as surgical options 
for the treatment of obesity and T2DM with focus on duodenojejunal and proximal 
jejunal bypass.
Keywords: sleeve gastrectomy with bypass, sleeve-plus, duodenojejunal bypass, 
proximal jejunal bypass, morbid obesity, type 2 diabetes, bariatric surgery in Asia
1. Introduction
Obesity rates continue to increase globally, as well as the number of bariatric 
surgeries done. The RYGB is considered the gold standard bariatric surgery due to 
its satisfactory weight loss and remission of T2DM and other morbidities. However, 
the technical complexity and its long-term complications have led to a decrease in 
popularity over SG, which is easier to do with also satisfactory outcomes in weight 
loss and resolution of morbidities. However, SG also has its own shortcomings such as 
long-term weight regains and recurrence of co-morbidities. In an attempt to improve 
outcomes and decrease complications, new procedures are developed. Supplementing 
an intestinal bypass to an SG results in a simpler technique that has the physiologic 
advantages of RYGB but minimized adverse effects. The term for such procedures 
was coined as “sleeve-plus” by Dr. Chih-Kun Huang in the Taiwan Surgical Society of 
Gastroenterology meeting on October 24, 2015 [1]. As there have been several types 
of sleeve-plus techniques, this chapter will give a more comprehensive discussion on 
sleeve-plus procedures more commonly done in the Asia-Pacific region: the duodeno-
jejunal bypass (DJB) and the proximal jejunal bypass (PJB).
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2. World statistics and census
Obesity is a major non-communicable epidemic disease and has been increasing 
worldwide for both developed and developing countries. It has tripled in number 
since 1975 according to the World Health Organization (WHO), with the latest 
data showing more than 1.9 billion adults classified as overweight; 650 million of 
which are considered as obese. In 2016, obesity accounted for 13% of the world’s 
population (11% of men, 15% of women) [2]. In the Asia-Pacific region, the 
obesity in Gulf countries is greater than 30%, with T2DM frequency at 8-14.7%. 
This is in contrast to most of the other Asian countries where diabetes was more 
frequently seen than obesity [3].
Bariatric surgery is recognized as the most efficacious treatment for morbid 
obesity and its accompanying co-morbidities [4]. The International Federation 
for the Surgery of Obesity and Metabolic Disorders (IFSO) 5th Global Registry 
Report in 2019 recorded 520,983 bariatric operations performed from 2015 to 2018. 
The predominating bariatric surgery was SG (58.6%) followed by RYGB (31.6%) 
[5]. The Asia-Pacific Bariatric and Metabolic Surgery Society 2018 Congress 
reported 95,125 surgeries in Asia-Pacific countries, with most being performed in 
Australia and the Gulf countries, reflecting the highest obese populations in Asia. 
The most commonly performed was SG (68%), followed by the different bypass 
procedures (19.5%), and other surgeries, including revisional surgery (12.5%). 
Sleeve gastrectomy is being done at more than 50% of the procedures in most 
countries. The reported bypass surgeries included RYGB, one-anastomosis gastric 
bypass, SG with duodenojejunal bypass (SGDJB), and biliopancreatic duodenal 
switch (BPPDS). The bypass procedures were more than 30% only in Thailand and 
India. The OAGB was the leading bypass procedure in Taiwan, India and the Gulf 
countries. The SGDJB was more common in Japan, while RYGB was more common 
in the other countries [3].
The gold standard in bariatric surgery is still RYGB; but due to its technical 
difficulty and more severe complications such as marked malnutrition and marginal 
ulceration, SG has become the more popular bariatric procedure.
3. Brief evolution of bariatric surgery
Bariatric and metabolic surgery originated in the early 1950s, first performed 
by Kremen: the jejunoileal bypass. To treat obesity-associated hyperlipidemia, 
the proximal jejunum was anastomosed to the distal ileum to limit absorption. 
However, this was associated with post-operative severe malnutrition and liver 
complications [6]. Taiwan was the first country in Asia recorded to perform the 
jejunoileal bypass for obesity treatment in 1974 [7]. The initial bariatric surgery 
was modified to limit malabsorption. In 1960s, Mason developed the first gastric 
bypass procedure utilizing a transverse gastric pouch remnant anastomosed to a 
loop of jejunum. Severe bile reflux prompted revision to a Roux-en-Y reconstruc-
tion of gastric bypass in the 1970s, which resulted to less diarrhea, kidney stones 
and gallbladder stones [6]. Taiwan was the first to perform a gastric partition 
in 1981. Vertical banded gastroplasty then began in Japan in 1982, and then 
Singapore in 1987 [7].
Biliopancreatic diversion (BPD) by Scopinario and duodenal switch (DS) by 
Hess were also developed subsequently in 1976 and 1988; but the high incidence 
of potential metabolic complications and prolonged follow-up made these proce-
dures less common. The RYGB eventually became the gold standard procedure for 
bariatric surgery [4].
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In an attempt to breakdown RYGB and laparoscopic DS to decrease the opera-
tive time, SG was initially performed as a first step of a staged procedure [8]. The 
achievement of weight loss after SG made it an adequate stand-alone procedure.
Laparoscopic bariatric surgeries were first performed in 1994: laparoscopic 
adjustable gastric banding (LAGB) by Belachaew, and laparoscopic RYGB by 
Wittgrove and Clark. Asia also started laparoscopic bariatric surgeries during the 
1990s [3]. In 1999, laparoscopic BPDDS was initiated by Gagner; and laparoscopic 
classical BPD by Scopinario. By 2000, McMahon and Gagner performed the first 
isolated laparoscopic SG, which was the time that majority of bariatric surgeries 
were already being done laparoscopically [5, 9].
Advancements in minimally invasive surgery lead to the application of single 
incision laparoscopic surgery (SILS) to bariatric surgery. In 2008, Nguyen 
reported the first case of bariatric SILS with adjustable gastric banding, [10] 
while Saber performed SILS SG [11]. Huang documented the first single incision 
transumbilical (SITU) RYGB in 2009, [12] followed by a series in 2010 compar-
ing surgical outcomes of patients undergoing 5-port LRYGB with the novel 
SITU RYGB. The SILS has been shown to improve patient satisfaction in terms 
of cosmesis with comparable weight loss and morbidity rate. However, techni-
cal challenges due to the restricted surgical field, longer operative time, and 
increased post-operative pain have limited its popularity [13]. These procedures 
are technically feasible and reproducible with proper patient selection, performed 
by an experienced surgeon.
Restrictive and malabsorptive anatomic conceptualization of bariatric surgi-
cal procedures are continually under investigation. Modifications to the accepted 
standards are being made to further improve the treatment of obesity-related 
co-morbidities and reduce the impact of surgery.
4. Types of sleeve-plus procedures
The earliest sleeve-plus procedure is the BPDDS which was developed in 1998 by 
Hess and Marceau [14, 15]. Many of the sleeve-plus procedures were patterned after 
the BPDDS. The procedure consists of a Roux-en-Y reconstruction of the bowel with 
a duodeno-ileal anastomosis for the alimentary limb, a lengthy biliopancreatic limb 
for malabsorption, and a short common limb. Changes in the location of the limb 
anastomosis and the limb lengths resulted in the different sleeve-plus techniques 
reported today (Figure 1).
In 2007, Sanchez-Pernaute reported a modification of the BPDDS into a loop 
fashion of limb reconstruction with a longer common channel. He described it as a 
single anastomosis duodenoileal bypass with sleeve (SADI-S) [16]. Santoro devel-
oped the SG with transit bipartition as an ileal anastomosis to the SG antrum with 
a Roux-en-Y reconstruction. This technique was then revised by Mui into a loop 
fashion and was called single anastomosis sleeve ileal bypass (SASI) [17, 18].
The sleeve gastrectomy duodenojejunal bypass (SGDJB) was first developed in 
Asia as an alternative to RYGB to allow the stomach to be screened for gastric cancer 
in areas with a high-risk population. The procedure may be done in the Roux-en-Y 
or loop fashion and was developed by Kasama in Japan and Huang in Taiwan, 
respectively [19, 20].
The ileal interposition with sleeve gastrectomy (IISG) was introduced by 
Aureo De Paula. The procedure included a segment of the ileum placed between 
the transected proximal duodenum and to the proximal jejunum, or interposed 
into the proximal jejunum [21]. The complexity of the procedure limits its wide-
spread application.
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Figure 1. 
Types of sleeve-plus procedures.
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The proximal jejunal bypass (SGPJB) is probably the simplest sleeve-plus 
procedure to perform. It was developed by Alamo in 2004, where the proximal 
20 cm of the jejunum is transected and anastomosed to the distal 300 cm bowel, 
leaving a blind-ended segment of the jejunum [22].
5. Advantages of sleeve-plus procedures
Several advantages can be gained from sleeve-plus procedures. First, it allows 
the remaining stomach to be screened for gastric cancer, which is frequently done in 
areas of high gastric cancer prevalence such as Japan and Korea [23]. Screening will 
be difficult to do in RYGB.
In the techniques where anatomical and functional preservation of the pylorus 
is done, the gastric mucosa is protected against pancreatic and biliary fluids; hence, 
preventing bile acid gastritis [24]. The pylorus also regulates gastric emptying which 
results to a lower incidence of dumping syndrome [25]. The larger gastric mucosal 
contact to food in SG compared to that in RYGB also improves the absorption of 
iron, calcium, vitamin B12 and protein leading to less nutritional deficiencies [26].
Sleeve-plus procedures are quite versatile if a conversion to another procedure 
become warranted, whether due to weight regain, or complications of leaks and 
strictures. The loop SGDJB may be converted to a DS by transecting the afferent 
limb and anastomosing it to the distal segment of the efferent limb. The Roux-en-Y 
SGDJB can also be converted into DS by lengthening the alimentary limb from 
the biliopancreatic limb. Conversion to RYGB of any sleeve-plus procedure is also 
feasible. Index sleeve-plus procedures with a transected duodenum requires the 
proximal duodenal anastomosis to be taken down to allow resection of the distal 
gastric tube. The previous alimentary limb is then anastomosed to the remaining 
gastric pouch. In an SGPJB, a gastric pouch is simply created and anastomosed to 
the blind limb to construct the alimentary limb. In SG with bipartition, the gas-
troenteric anastomosis is transected, a gastric pouch is created, and a Roux-en-Y 
reconstruction of the bowel is done.
Loop techniques of sleeve-plus procedures have an additional advantage over the 
Roux-en-Y techniques. The single anastomosis in loop procedures allow for a shorter 
operative time and less potential complications that may arise from every additional 
anastomosis. The number of anastomoses also translates to the number of man-made 
hernial defects that necessitates closure. Another advantage of the loop techniques is 
that marginal ulcers have not been reported [20]. This may be due to the immediate 
neutralization of the gastric fluid by the bile juices once in the duodenum.
6. Hormonal effect of sleeve-plus procedures
When food is ingested, there are changes in the entero-insular axis which 
involve the gastrointestinal, endocrine and pancreatic secretions that contribute 
to insulin production. The main hormones in this mechanism includes ghrelin, 
glucagon-like polypeptide (GLP-1), peptide YY (PYY), gastric inhibitory peptide, 
oxyntomodulin, and cholecystokinin. Anatomical alterations of the food passage-
way can affect these entero-hormones which can both influence the central regu-
lation of body weight homeostasis, and make glycemic control more efficient. The 
hormones affect the hypothalamic-appetite regulation and suppress food intake. 
The enhanced glucose homeostasis can be explained by “foregut” and “hindgut” 
theories. The foregut theory hypothesizes that exclusion of food contact with the 
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duodenum prevents secretion of “anti-incretin” substances. Incretins are meta-
bolic hormones that promote a decrease in blood glucose by making the pancreas 
more efficient. On the other hand, the hindgut theory explains that contact of 
undigested food immediately into the distal bowel stimulates production of incre-
tins. The more relevant incretins involved are the GLP-1 and the PYY. These are 
produced from the L-cells in the distal ileum and colon after immediate contact 
with nutrients. The postprandial GLP-1 levels are significantly increased after 
both RYGB and LSG [27–29].
The sleeve-plus procedures are comprised of a sleeve gastrectomy and an 
intestinal bypass component. Sleeve gastrectomy has been shown to significantly 
decrease ghrelin, an orexigenic hormone predominantly secreted in the stomach. 
Ghrelin is also known to suppress insulin and have a modulating effect on glucose 
homeostasis, hence the decreased levels after SG also helps improve blood sugar 
control [30]. The SGPJB and SGDJB both have additional glycemic control effect 
by allowing food to be in early contact to the distal jejunum, stimulating earlier 
incretin production. The SGDJB has the added benefit of bypassing the duodenum 
and averts secretion of anti-incretin substances [31].
6.1 Hormonal study
A prospective observational study was conducted by Dr. Chih-Kun Huang on 
the incretin effect of SGDJB in type II diabetic patients with BMI <35 kg/m2 from 
May 2013 to March 2014. The study included 27 patients, 23 females and four males, 
mean age of 51, mean weight at 74.5 kg and mean BMI 28.4 kg/m2. All patients have 
T2DM for a mean duration of 10 years and underwent SGDJB with an afferent limb 
of 200 cm. The C-peptide, ghrelin, GLP-1, PYY were measured over time together 
with an oral glucose tolerance test (OGTT).
Hormone levels were analyzed by time courses, area under the plasma con-
centration time profile (AUC) and maximum plasma concentration (Cmax). 
Follow-up hormone levels were compared using the paired t-test. The fisher exact 
test was used when 20% of the cells had expected values of less than 5. A p-value 
of less than 0.05 denoted statistical significance. All statistical tests were 2-tailed 
and calculated using the SPSS statistical software (version 15.0; SPSS Inc., 
Chicago Il.)
The surgery resulted in substantial weight loss with good glycemic control. At 
six months, the mean BMI had decreased to 22 (p < 0.01), fasting glucose from 
160 to 111 gm/dL, and mean glycosylated hemoglobin levels from 9.3 to 6.28% 
(p < 0.01). Fasting ghrelin assays over time alongside OGTT was significantly lower 
with an AUC-120 of 82.13 ± 49.36 pg./mL/min dropping down to 17.90 ± 9.01 pg./
mL/min (p < 0.05). The GLP-1 showed an exaggerated response with an AUC-120 
increase from 139.37 ± 109.93 pg./mL/min preoperatively to 349.10 ± 187.35 pg./
mL/min at one month (p < 0.05) and to 185.75 ± 118.81 pg./mL/min at six 
months (p = 0.06). The PYY also showed significant postprandial response at 
one month postoperatively with and AUC-120 change from 137.10 ± 93.20 pg./
mL/min to 454.50 ± 134.85 pg./mL/min (p < 0.05). However, this dropped to 
136.57 ± 134.53 pg./mL/min at six months (p = 0.987) postoperatively (Figure 2).
The results in this hormonal study can infer that SGDJB leads to the immediate 
decrease in hunger, increase in satiety and better glycemic control. However, the 
decrease in PYY levels after six months is different from that of other hormonal 
studies where GLP-1 and PYY were shown to be elevated up to one year after bar-
iatric surgery [32, 33]. Further research is needed to confirm how long the elevated 
incretin levels can persist postoperatively and how the body eventually adapts to it.
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7. Indications and contraindications
The National Institute of Health (NIH) Consensus Conference in 1991 established 
the indications in performing bariatric surgery, at the height of the obesity epidemic. 
Since then, a few modifications were made differing from country to country. The 
National Institute of Health and Care Excellence (NICE) in UK, as well as the Asian 
Pacific Metabolic and Bariatric Surgery Society (APMBSS), extended the indications 
further in relation to presence of other co-morbidities and adjusted the BMI thresh-
old in accordance to inherent differences in body composition [34, 35]. In 2016, the 
2nd Diabetes Surgery Summit convened with leading international diabetes orga-
nizations and developed new recommendations for metabolic surgery with a lower 
BMI threshold for Asians due to the higher risk for diabetes despite lower BMI values 
[36, 37] (Table 1).
Contraindications to bariatric surgery include physiological, medical and surgi-
cal, and psychological factors; few are considered to be absolute contraindications 
(Table 2).
Physiological factors include age and BMI. Initial NIH guidelines have limited 
surgery to 18-65 years of age, but recent studies have shown that bariatric surgery is 
considered safe for the elderly population [38–41]. There are limited well-designed 
prospective studies on bariatric surgery for children and adolescents, and an 
important factor to take into consideration is the psychological maturity required in 
accepting the lifestyle changes accompanying surgical intervention.
Obstructive sleep apnea, diabetes, hypertension and cardiovascular problems 
are some of the health conditions that should be screened and controlled pre-
operatively prior to contemplating bariatric surgery. Previous abdominal surgery 
including abdominal wall hernias would influence practicality and applicability of 
any laparoscopic approach [4].
Figure 2. 
C-peptide and hormone assays at zero, one and six months after SGDJB against time in minutes alongside an 
oral glucose tolerance test.














Contraindications for bariatric surgery.
Active psychiatric disease and psychological instability are absolute contrain-
dications; while poorly controlled eating disorders being a negative predictor of 
post-operative weight loss, is a relative contraindication [42, 43]. Smoking has been 
associated with development of post-operative marginal ulceration after gastric 
bypass, increased risk of poor wound healing and impaired health, and should be 
stopped at least 6 weeks before surgery [4, 44].
7.1 Selection of sleeve-plus procedure
The SGDJB and SGPJB are both relatively more recent than the RYGB and the 
data is still too young to provide specific indications for either procedures. Both 
patient and surgical factors must be considered when choosing the appropriate pro-
cedure for a safe outcome with optimal weight loss and resolution of co-morbidities. 
Any contraindications to SG obviously preclude both SGDJB and SGPJB such as 
severe gastroesophageal reflux disease and Barrett’s esophagus.
All patients who are suitable candidates for SG may benefit from an additional 
bypass component if the BMI and diabetic history are considered. Higher BMIs 
such as 45 or more may benefit from a malabsorptive component but also reflect 
thicker visceral fat. This may pose difficulties during duodenal dissection for 
SGDJB. Hence, SGPJB may be a safer and easier option. Patients with long stand-
ing diabetes may also benefit from a bypass component because of the additional 
incretin response. Those with poorer glycemic control due to a more decompensated 
Criteria NIH NICE APMBSS DSS-IIi
BMI ≥ 40 ≥ 40 > 37 ≥ 40i
BMI with 
co-morbidities
≥35- • ≥ 35
• ≥ 35 with new onset 
diabetes
• 30 with new onset diabetes*
≥ 32** • ≥35i***
• ≥30i****
iBMI criteria is decreased by 2.5 for Asians.
*Bariatric surgery can be considered in BMI 30-34.9 with new onset diabetes.
**Presence of diabetes or two other obesity-related co-morbidities.
***Inadequately controlled hyperglycemia despite lifestyle and optimal medical therapy.
****Inadequately controlled hyperglycemia despite optimal medical treatment.
Table 1. 
Indications for bariatric surgery.
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pancreas may consider SGDJB over SGPJB due to the combined glycemic effects 
from the foregut and hindgut theory. However, SGDJB is a challenging procedure 
and requires a more experienced surgeon’s skill set.
Intraoperative findings may also influence the choice of procedure. Any evidence 
of vascular perfusion concerns on otherwise normal tissues may hint potential 
anastomotic problems. An SGPJB may be a more practical option, as the leaks from 
jejuno-jejunal anastomosis is easier to manage than leaks from a duodenojejunal 
anastomosis. The patient’s current medical condition must also be considered. 
Severe co-morbidities such as cardiac issues may preclude contemplation for SGDJB 
as this requires a longer operative time compared to SGPJB.
Each surgery has its own advantages and disadvantages. However, a safe out-
come is still the most important factor to consider when choosing not only between 
sleeve-plus procedures, but for any type of bariatric surgery.
8. Preoperative considerations
A multidisciplinary team is necessary for screening and evaluating a patient’s 
medical condition including psychological capability to undergo bariatric surgery. 
One of the crucial facets in the success of bariatric surgery is a comprehensive medi-
cal history, physical examination, preoperative work-up, with patient education 
playing an integral part.
A complete history should include a detailed diet history, physical activity, 
medication review, social history, psychological history, and psychosocial factors 
that can affect the surgical outcome. All body systems are assessed. A full endocri-
nologic evaluation is done to rule out other causes of obesity. Other obesity-related 
co-morbidities are screened and managed accordingly.
Psychological evaluation is necessary to identify any undiagnosed psychiatric 
disorders, and to assess if a candidate will be able to undergo the lifestyle changes 
necessary to sustain long-term weight loss. Any significant psychiatric problems 
must be treated and controlled prior to any contemplated procedure. Counseling for 
smoking and alcohol cessation, as well as pregnancy must be included.
9. Operative technique
The addition of a bypass component to a simple SG would entail a more tech-
nically challenging surgery. Advanced laparoscopic skills are essential to safely 
perform organ manipulations, adequate dissection, landmark identifications, sutur-
ing and anastomosis to ensure a complete and successful surgery. Although several 
procedures are mentioned above, this chapter will give a more comprehensive 
discussion to SGDJB and SGPJB, which are the more commonly performed sleeve-
plus procedures in the Asia-Pacific region.
9.1 Duodenojejunal bypass
There have been two operative techniques describing SGDJB: the Roux-en-Y 
(RNY) and the loop technique. The RNY SGDJB was first described by Kasama in 
2009 as an alternative option to RYGB which precludes screening of the remnant 
stomach for gastric cancer in high-risk populations as in Japan [19]. The loop 
 technique was then described by Huang in 2013 in an attempt to mitigate some  
long-term complications associated with RYGB [20].
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9.1.1 Roux-en-Y technique
After induction of anesthesia, the patient is placed in the French position. Five 
ports are inserted, the camera port at the supra-umbilicus, a 5-mm port at the 
subxiphoid for liver retraction, two 12-mm ports at the left subcostal margin and 
10 cm caudally, and a 15 mm port at the right upper abdomen.
A standard SG is done over a 36 French bougie using linear staplers beginning 
4 cm from the pylorus and proceeding proximally. Dissection of the posterior wall 
of the duodenum is done and transected at 1-2 cm distal to the pylorus. The jejunum 
is transected at 50-100 cm from the ligament of Treitz serving as the biliopancreatic 
limb. The transected distal jejunum to serve as the alimentary tract is measured to 
150-200 cm where the jejunojejunostomy anastomosis of the biliopancreatic limb 
is done. The mesenteric defect is closed by hand-sewn technique. The omentum is 
divided to avoid tension on the antecolic reconstruction of the duodenojejunal end-
to-side anastomosis [19] (Figure 3).
9.1.2 Loop technique
After anesthesia is initiated, the patient is placed in supine position. Five ports 
are also used. Two 12-mm ports at the left and right of the umbilicus at the midcla-
vicular line; the left serving as the camera port. A 15-mm port is inserted into the 
umbilicus and two 5-mm ports at both subcostal margins.
A standard sleeve gastrectomy is done over a 36 French bougie using a linear 
stapler beginning at 4 cm proximal to the pylorus and proceeding cranially. At the 
duodenum 2 cm distal to the pylorus, the posterior wall is dissected creating a tun-
nel where the linear stapler is inserted and used for transection. The jejunum is then 
measured 200-300 cm from the Ligament of Treitz where an enterotomy is created. A 
1.5 cm duodenotomy is created at the proximal limb and anastomosed to the enter-
otomy by hand-sewn technique. The jejunum 4 cm proximal to the duodenojejunos-
tomy is anchored to the antrum serving as an anti-torsion suture. The Petersen’s defect 
is closed. The remnant stomach is fixed posteriorly to the retroperitoneal fat and a 
Jackson-Pratt drain is placed behind the duodenojejunal anastomosis [20] (Figure 4).
9.1.3 Pearls
The SGDJB can be quite intimidating to some surgeons due to the intimate 
relationship of the duodenum to the surrounding structures. Proper identification 
of landmarks to guide dissection is important to avoid mishaps.
The location of the common bile duct running behind the first portion of the 
duodenum, serves as a boundary to the second portion where the transection is 
done. The gastroduodenal artery (GDA) is also located in this area just to the left 
of the common bile duct (Figure 5). Hence, dissection of the duodenum from the 
pancreas must be done carefully to avoid injury and bleeding due to the proximity 
of the GDA and high vascularity of the area.
To facilitate the dissection, counter-traction of the duodenum may be done 
by pulling the stomach laterally to the left using a traction suture over the gastric 
antrum. In patients with excessive periduodenal fat, the dissection of a tunnel 
below the duodenum becomes difficult. In these cases, the right gastroepiploic 
vessels may be sacrificed. Once a clear tunnel between the duodenum and pancreas 
has been created, a vascular tape may be inserted and used to lift the duodenum to 
assist insertion of a stapler for the duodenal transection (Figure 6). The surgeon 
must take care not to injure the common bile duct, pancreas and vasculatures 
around the first part of the duodenum. A side-to-side or end-to side duodenojejunal 
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anastomosis may be done, each having its own precautions. A side-to-side anasto-
mosis must be done 1 cm distal to the pylorus to avoid its injury. A temporary stay 
suture between the pylorus and proximal jejunum allows for easier hand-sewn anas-
tomosis. The other option of an end-to-side anastomosis would require the posterior 
wall of the proximal duodenum to be partially devascularized to allow some tissue 
clearance for the hand-sewn anastomosis. Use of a stapler in both orientation of 
anastomosis may risk pyloric injury. The loop technique requires only a single anas-
tomosis, and an anti-torsion suture anchoring afferent limb of the jejunal loop to 
the stomach. This is done to avoid torsion or kinking of the jejunal limbs. The RNY 
technique would require another entero-enteric anastomosis which would translate 
to more operative time. Closure of both the Petersen and mesenteric defect prevents 
potential internal herniation of bowel.
Figure 3. 
SGDJB roux-en-Y technique.
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Figure 5. 
Anatomical landmarks and relationships of the proximal duodenum.
Figure 6. 
Use of a vascular tape to maneuver the duodenum facilitates application of the stapling device.
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9.1.4 Challenges
Apart from being an irreversible procedure with no long-term data avail-
able yet to compare it to RYGB, the procedure is technically demanding and 
might preclude super obese patients. It also requires a fastidious surgeon with 
Figure 7. 
Sleeve gastrectomy with proximal jejunal bypass.
15
Sleeve-Plus Procedures in Asia: Duodenojejunal Bypass and Proximal Jejunal Bypass
DOI: http://dx.doi.org/10.5772/intechopen.96042
meticulous skills in manipulating an area of intimately-related vital structures, 
so as to have an uneventful surgery.
Duodenal dissection and manipulation must be done carefully to avoid inad-
vertent damage to the duodenal wall. Injury to the duodenum proximal to the 
dissection is resolved with the duodenojejunal anastomosis. But injury distal to the 
transection may result in a leak if not repaired properly.
Bile duct injury may occur if the duodenal transection is done too distally. 
Avulsions and lacerations are repaired over a T-tube inserted into the bile duct. 
Complete transections would require a biliary reconstruction.
Bleeding is not infrequent due to the vascularity around the proximal duodenum 
and may range from oozing to torrential. Oozing due to multiple small vessels is 
controlled with simple packing until hemostasis is achieved. Added manipulation 
is avoided to prevent more tissue injury and aggravate hemorrhage. Severe bleeding 
from an injured gastroduodenal artery may necessitate suture repair, ligation or 
conversion to an open laparotomy.
Another shortcoming of the SGDJB is the inaccessibility to the Ampulla of Vater 
for endoscopic management of biliary obstructions. Therefore, patients with chole-
lithiasis preoperatively are offered cholecystectomy concomitantly with the bariat-
ric surgery or subsequently if it develops postoperatively, regardless of symptoms.
9.2 Proximal Jejunal bypass
The surgery is performed under general anesthesia with the patient in reverse 
Trendelenberg position. Initial entry and camera port is done along the left upper 
quadrant followed by the other working ports: 15 mm at the umbilicus, 5 mm at the 
right upper quadrant, and 5 mm at the left subcostal area.
A standard SG is done over a 36 French bougie using linear staplers beginning 
4 cm from the pylorus and proceeding proximally. The ligament of Treitz is identi-
fied and jejunum is divided at 20 cm. The distally transected jejunum is measured to 
a distance varying from 250 to 300 cm and is anastomosed to the proximal biliopan-
creatic jejunal limb. The mesenteric defect is closed to avoid internal hernia and the 
remnant stomach is fixed posteriorly to the retroperitoneal fat [45] (Figure 7).
10. Postoperative care and follow up
Once the surgery has been concluded, extubated and recovered from anesthesia, 
the patient is then returned to the ward. Clear liquids are initiated once the patient 
is fully awake. Deep breathing exercises and chest physiotherapy are done. Early 
mobilization is encouraged and opioid analgesics are used for pain control. If there are 
no remarkable events, the patient is discharged and is scheduled to follow up after one 
week at the out-patient clinic. Diet progression is then continued as with any routine 
bariatric diet, with a progressive exercise program in place. Maintenance medications 
for diabetes and other co-morbidities are adjusted accordingly. Prophylactic proton 
pump inhibitors may be given. Subsequent follow-ups include dietary counseling, and 
is done every three months after the surgery for the first two years and then annually.
11. Therapeutic outcomes
Review of literature has reported RYGB to have better results than LSG in terms 
of weight loss and T2DM remission. However, complications are also reported to 
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be higher after RYGB [46, 47]. Up to 97% of morbidly obese SG patients have been 
reported to have improvement or remission of T2DM at 13 months but drops to 
60.8% at five years with a recurrence rate of 13% [48]. Early reports of DJB in non-
obese diabetic patients have shown improvement in sugar control albeit without 
remission of diabetes [49, 50]. Since there was no SG done, this suggests that weight 
loss is a strong factor for diabetes remission. The combination of SG with an intesti-
nal bypass results to a synergistic combination of weight loss and sugar control.
The SGDJB was first reported by Kasama et al. in 2009, in comparison with 
gastric band, RYGB and SG. At one year, the excess weight loss (EWL) was similar 
to RYGB, and better than SG or gastric banding. Diabetes resolution of SGDJB 
was better than SG at 93% versus 67%. There was also resolution of dyslipidemia 
(100%) and hypertension (85.7%) [19]. Raj et al. published a randomized controlled 
trial between SGDJB and RYGB showing no statistical difference in percent EWL, 
diabetes remission, and resolution of hypertension and dyslipidemia [51]. Lee et al. 
also compared SGDJB with RYGB showing better EWL with SGDJB (80.3% vs. 
63.4%) but with higher cholesterol levels than RYGB [26]. He also compared SGDJB 
to SG alone and reported SGDJB to have better weight loss (EWL 87.2% versus 
67.5%) and diabetes remission (93% versus 87%) [52].
Kasama’s group also reported the effect of SGDJB on glucose metabolism in 
morbid obesity with associated diabetes. Glucose monitoring showed decreasing 
insulin requirements on the first postoperative day to no diabetic medications on the 
second day. At one month, 91% of the subjects achieved an HbA1c below 7%. A meal 
tolerance test conducted at six months showed the subjects to have lower glucose 
and increased insulin area under the curve. This was reflected in the decreased 
requirement of oral hypoglycemic agents and insulin [53]. At one year, fasting blood 
sugar and HbA1c levels improved at 194 to 105 and 8.9 to 6.0, respectively, and 
found to be sustained up to five years with a reported remission rate of 63.6% [54].
In diabetic patients within the lower BMI range of obesity, Huang et al. reported 
that SGDJB resulted in a BMI drop to 22.4 from 28.4 in six months, and HbA1c levels 
below 7.0 without medications in 91% of the subjects [20]. On two-year follow-up, 
diabetes remission was found to be at 54% and glycemic control in 77% [55]. In com-
parison to RYGB, there were no statistical difference in the outcomes for diabetic 
patients with BMI less than 35 in terms of weight loss and glycemic control [56].
Studies on SGPJB have shown to the weight loss outcomes to be better than SG 
[57]. The EWL in one year is 96.7% and has been found to be sustained to more than 
80% even after 10 years of follow-up [58]. Good glycemic control is also achieved 
after SGPJB. In 2016, the first Asian series was reported by Huang et al. showed 66% 
EWL at six months, with 66.7% of diabetic patients achieving an HbA1c less than 6 
without medications [45]. A study on diabetics with BMI of <35 showed 97% of the 
subjects on preoperative oral hypoglycemic agents had complete remission and all of 
the subjects on insulin to be in partial remission [59]. When compared with RYGB, 
the outcomes at one and three years showed weight loss and diabetes remission to be 
similar, with both groups requiring less medications [60, 61].
12. Complications
The overall morbidity associated with bariatric surgery complications ranges 
from 3.4-13% and may vary depending on the procedural type, surgical approach, 
patient age, BMI and co-morbidities [62–64]. Literature will show that SG has an 
overall complication rate lower than RYGB [65, 66]; however, potential complica-
tions associated with SG remains worrisome, including post-operative hemorrhage 
and staple line leak.
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12.1 Hemorrhage
Significant post-operative hemorrhage after bariatric surgery has been described up 
to 3.4%, [67] with the most common presenting symptom as tachycardia (46%), fol-
lowed by melena (32%). Sleeve gastrectomy bleeding can happen from the short gastric 
vessels or along the staple line after transection of the stomach [68]. Bleeding can also 
occur from an anastomotic site intraluminally in patients with an additional bypass 
procedure which typically may be managed medically or endoscopically. Surgery should 
be considered for hemodynamic instability and failure of endoscopic therapy [67].
12.2 Leak
One of the most dreaded complication after bariatric surgeries are anastomotic 
leaks or staple-line leaks. Leaks from SG can occur along the staple-line, with an 
average incidence of 1.5% [69]. Risk factors that contributed to gastrointestinal leak 
include oxygen dependency, hypoalbuminemia, sleep apnea, hypertension and dia-
betes. Additional factors that contributed to a higher leak rate include intraoperative 
provocative testing and placement of drain [70].
Clinical presentation of patients with leaks range from completely asymp-
tomatic, to frank peritonitis, septic shock, and death. Unexplained tachycardia 
has been shown to be an initial sign of early leak [71]. Other potential signs that 
should cause a high index of suspicion should include fever (>38C), diffuse 
abdominal tenderness, cough, and persistent hiccups [72]. A concern about 
a leak should be investigated urgently with imaging modalities such as upper 
gastrointestinal series with water-soluble contrast or abdominal CT scan IV and 
oral contrast. Urgent reoperation is warranted for unstable patients with signs of 
sepsis. Stable patients with controlled leaks may undergo percutaneous drainage, 
antibiotic therapy and nutritional support, in conjunction with endoluminal 
therapies (stenting, clipping) [4, 72].
12.3 Sleeve gastrectomy related complications
12.3.1 Gastroesophageal reflux disease
Another SG related complication is new-onset gastroesophageal reflux disease 
(GERD), or worsening of previous GERD symptoms. A meta-analysis by Yeung et 
al. demonstrated significant worsening of GERD post-operatively at 19%, with de 
novo GERD at 23% [73]. Long-term follow up of patients show 28% of LSG patients 
develop esophagitis, and 8% develop Barrett’s esophagus. Endoscopic assessment 
for presence of hiatal hernia is recommended pre-operatively, as its concomitant 
repair during SG can help reduce incidence of post-operative GERD [74].
12.3.2 Gastric tube stenosis
Post-SG stenosis is a rare complication with a reported incidence of 1% – 3.5% 
[75, 76]. The most common site for stenosis is at the incisura angularis, [76] usually 
presenting with gastric outlet obstruction symptoms with marked weight loss and 
malnutrition [4]. Diagnosis can be done with upper gastrointestinal series or con-
trast enhanced CT scan of the upper abdomen. Factors that contribute to develop-
ment of stenosis include bougie size and oversewing of the staple line. Endoscopic 
dilatation is the first line of treatment which usually require multiple sessions. 
Failure of endoscopic intervention, long segment stenosis, or presence of delayed 
leakage, abscess or fistula formation necessitates surgical intervention [75, 76].
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12.4 Intestinal bypass related complications
12.4.1 Hernia
Reconstruction of the intestinal continuity leads to man-made defects that 
may potentially result in internal hernias if not closed. Patients would present 
signs and symptoms of bowel obstruction and gangrene which are supported with 
radiologic findings. The incidence in SGDJB and SGPJB has been reported to be 
at 1-2% [51, 54, 60]. Despite the low incidence, defect closure still prevents the 
potential morbidities of internal hernia including necrosis and ischemia in 7-42% 
and associated mortalities [8].
Trocar site hernias are also a potential morbidity if facial defects more than 
10 mm are not closed. When trocar sites where dilatated to allow extraction of 
specimens, this must also be closed [77].
12.4.2 Malnutrition
The addition of an intestinal bypass to sleeve gastrectomy has implications to the 
patient’s nutritional status as it alters the natural absorption of nutrients. The larger 
stomach in sleeve-plus procedures allow more acid and intrinsic factors to have 
better absorption of iron, calcium, and vitamin B12 compared to an RYGB.
Comparison of SGDJB to SG alone has not shown any difference in nutritional 
status at one year [22, 52]. Investigational studies of SGDJB done in Chinese diabetic 
patients with BMI <25 kg/m2 has shown an increased incidence of becoming under-
weight and deficiencies in iron, vitamin B12, vitamin D and calcium [78].
In SGPJB, despite a defunctionalized intestinal segment, nutrient deficiency levels 
are comparable to SG. The preserved pyloric function and duodenal exclusion omit-
ted in SGPJB also results to a lower incidence of nutritional deficiencies, diarrhea (6% 
vs. 21.5%), dumping syndrome (0 vs. 7.6%) and fatigue (25.3% vs. 40.5%) [61].
Postoperative supplementation of vitamins and minerals are necessary to 
prevent post-operative malnutrition. More studies are needed to determine the 
nutritional deficiency of sleeve-plus procedures to properly guide supplementation 
of these patients.
12.4.3 Dumping syndrome
Reconstruction of the digestive anatomy also alters the glucose metabolism 
which may result to dumping syndrome. This occurs in 15-76% after RYGB and may 
be potentially debilitating. Preservation of the pylorus in both SGDJB and SGPJB 
allows for a more regulated gastric emptying and a lower reported incidence of 
dumping syndrome at 4% and 0%, respectively [53, 61].
12.4.4 Marginal ulcer
Marginal ulcers of the gastrojejunal anastomosis of the RYGB has been reported 
to occur up to 12% and can lead to bleeding, perforation or stenosis. This is in 
contrast to low incidence reported in SGDJB Roux-en-Y technique at 0.49%, and no 
reported incidence in the loop technique [39, 54].
12.4.5 Blind loop syndrome
The creation of a blind loop of intestine could cause bacterial overgrowth, 
the so-called ‘blind loop syndrome’ or ‘bacterial overgrowth syndrome’ (BOS). 
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However, the SGPJB has the benefit of a blind jejunal limb without passage of food 
or bile, and an isoperistaltic loop [79]. This helps mitigate against the possibility of 
BOS. Unlike in JIB having a shorter common channel, the SGPJB enteral anastomo-
sis has a longer common channel, in which bacterial concentration is significantly 
lower [60]. Incidence of BOS after SGPJB is still unknown, but intestine continuity 
can be easily reversed in case BOS develops.
13. Conclusion
The addition of a malabsorptive component to LSG has been coined as “sleeve-
plus”. The sleeve-plus procedures more commonly done in the Asia-Pacific are the 
SGDJB and SGPJB. The said procedures have both shown satisfactory outcomes in 
the treatment of obesity and related co-morbidities that are comparable to other 
bariatric procedures but with less adverse outcomes than that of RYGB and may be 
considered as alternative options. However, more studies are necessary to assess 
long-term outcomes in terms of diabetes remission, nutrition, and applicability to 
other racial populations.
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